@article{3583d56416e54feba98133813a8125ec,
title = "Cardiac sudden death in psychiatric patients",
keywords = "Cardiac sudden death, Psychotropics, QT interval, QT prolongation, Side effects",
author = "Hiroyuki Uchida and Takefumi Suzuki",
note = "Funding Information: Dr Uchida has received grants from Astellas Pharmaceutical, Eisai, Otsuka Pharmaceutical, GlaxoSmithKline, Shionogi, Dainippon-Sumitomo Pharma, Eli Lilly, Mochida Pharmaceutical, Meiji-Seika Pharma, and Yoshitomi Yakuhin and speaker{\textquoteright}s honoraria from Otsuka Pharmaceutical, Eli Lilly, Shionogi, GlaxoSmithKline, Yoshitomi Yakuhin, Dainippon- Sumitomo Pharma, Meiji-Seika Pharma, Abbvie, MSD, and Janssen Pharmaceutical within the past 2 years. Dr Suzuki has received speaker or manuscript fees from Astellas, Dainippon Sumitomo, Eli Lilly, Elsevier Japan, Janssen, Meiji Seika, Otsuka, and Weily Japan. The Canadian Psychiatric Association proudly supports the In Review series with an honorarium to the authors.",
year = "2015",
month = may,
day = "1",
doi = "10.1177/070674371506000501",
language = "English",
volume = "60",
pages = "203--205",
journal = "Canadian Journal of Psychiatry",
issn = "0706-7437",
publisher = "Canadian Psychiatric Association",
number = "5",
}
